Achieving Symptom Control in the Treatment of Gastroparesis: From Pills to Pacing

Clicks: 1
ID: 315735
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #318 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Gastroparesis is a chronic disorder of the stomach characterized by delayed emptying without mechanical obstruction. Affected patients experience nausea, vomiting, and a feeling of fullness. Achieving sufficient symptom control remains challenging. Aims The aim of this retrospective study was to analyse the use and effectiveness of current treatment options employed in a step-up approach: 1.Dietary changes, 2.pharmacological treatment (prokinetic drugs including domperidone and prucalopride, and laxatives), 3.pyloric interventions (endoscopic balloon dilation, gastric per-oral endoscopic myotomy (G-POEM), laparoscopic surgical pyloromyotomy), and 4.gastric electrical stimulation (GES, EnterraTM). Methods All patients treated for gastroparesis at a tertiary hospital by a dedicated team between 01/2025 and 01/2026 were included. Diagnosis was confirmed by gastric emptying scintigraphy. Exclusion criteria were previous upper gastrointestinal tract surgery, concomitant hiatal hernia or gastroesophageal reflux disease (GERD), and intestinal failure. Main outcome was sufficient symptom control at the latest available follow-up defined as improved or contained symptoms without need for treatment escalation. Results Fifty patients were included. Median age was 39 years (IQR 25-57), 66% were female. Reasons for gastroparesis was idiopathic in 80%, diabetes in 8%, and rheumatologic or neurologic disease in 12%. Most frequent symptoms were feeling of fullness (82%) and nausea (74%). Sufficient symptom control following conservative treatment was achieved in 13 patients (26%). Eighteen patients (36%) underwent at least one pyloric intervention [G-POEM (n=5), dilatation (n=10), laparoscopic pyloromyotomy (n=5)], with five patients (10%) achieving sufficient symptom control. Fifteen patients (30%) received a GES device, of which two-thirds (n=10) achieved sufficient symptom control. Twenty patients (40%) had at least two interventions during their treatment course. Conclusion Adequate symptom control often requires escalation beyond conservative treatment. Many patients need multiple interventions, emphasizing the chronic nature of gastroparesis. These findings highlight the importance of an individualized, multimodal treatment approach and the need to further investigate predictors of treatment response.
Reference Key
openalex_W7163331614 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors C Hanreich, N Moser, P Aeschbacher, Y Borbély
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag055.063
URL
https://doi.org/10.1093/bjs/znag055.063
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.